From: Lung nodules and IgG4 related disease: a single-center based experience
Treatments | Â | Patients with lung nodules n (%) |
---|---|---|
Pred only | Â | 21 (42.0) |
Pred+immunosuppressive agents | Pred+CYC | 17 (34.0) |
Pred+MMF | 2 (4.0) | |
Pred+MTX | 3 (6.0) | |
Pred+AZA | 1 (2.0) | |
others | Â | 6 (12.0) |